Therapeutic effect of mizoribine on bullous pemphigoid associated with membranous nephropathy
- 31 March 2009
- journal article
- research article
- Published by Elsevier BV in Journal of the American Academy of Dermatology
- Vol. 60 (3), 523-524
- https://doi.org/10.1016/j.jaad.2008.09.009
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Changing mizoribine administration from three divided doses to one single dose induced remission of relapsed membranous nephropathyNephrology Dialysis Transplantation, 2006
- Correlation of clinical severity and ELISA indices for the NC16A domain of BP180 measured using BP180 ELISA kit in bullous pemphigoidJournal of Dermatological Science, 2005
- A randomized open-label comparative study of conventional therapy versus mizoribine onlay therapy in patients with steroid-resistant nephrotic syndrome (postmarketing survey)Clinical and Experimental Nephrology, 2004
- BP180 ELISA using bacterial recombinant NC16a protein as a diagnostic and monitoring tool for bullous pemphigoidJournal of Dermatological Science, 2002
- Functional Interaction of the Immunosuppressant Mizoribine with the 14-3-3 ProteinBiochemical and Biophysical Research Communications, 2000